| pubmed-article:16260821 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16260821 | lifeskim:mentions | umls-concept:C0002395 | lld:lifeskim |
| pubmed-article:16260821 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:16260821 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:16260821 | lifeskim:mentions | umls-concept:C0008425 | lld:lifeskim |
| pubmed-article:16260821 | lifeskim:mentions | umls-concept:C0150320 | lld:lifeskim |
| pubmed-article:16260821 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
| pubmed-article:16260821 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:16260821 | pubmed:dateCreated | 2005-11-1 | lld:pubmed |
| pubmed-article:16260821 | pubmed:abstractText | Reality orientation therapy combined with cholinesterase inhibitors has not been evaluated in patients with Alzheimer's disease. | lld:pubmed |
| pubmed-article:16260821 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16260821 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16260821 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16260821 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16260821 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16260821 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16260821 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16260821 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16260821 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:16260821 | pubmed:issn | 0007-1250 | lld:pubmed |
| pubmed-article:16260821 | pubmed:author | pubmed-author:OnderGraziano... | lld:pubmed |
| pubmed-article:16260821 | pubmed:author | pubmed-author:FrisoniGiovan... | lld:pubmed |
| pubmed-article:16260821 | pubmed:author | pubmed-author:ZanettiOrazio... | lld:pubmed |
| pubmed-article:16260821 | pubmed:author | pubmed-author:BernabeiRober... | lld:pubmed |
| pubmed-article:16260821 | pubmed:author | pubmed-author:GiacobiniEzio... | lld:pubmed |
| pubmed-article:16260821 | pubmed:author | pubmed-author:SilveriMaria... | lld:pubmed |
| pubmed-article:16260821 | pubmed:author | pubmed-author:BartorelliLui... | lld:pubmed |
| pubmed-article:16260821 | pubmed:author | pubmed-author:CarboneGabrie... | lld:pubmed |
| pubmed-article:16260821 | pubmed:author | pubmed-author:LambertucciPa... | lld:pubmed |
| pubmed-article:16260821 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16260821 | pubmed:volume | 187 | lld:pubmed |
| pubmed-article:16260821 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16260821 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16260821 | pubmed:pagination | 450-5 | lld:pubmed |
| pubmed-article:16260821 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:meshHeading | pubmed-meshheading:16260821... | lld:pubmed |
| pubmed-article:16260821 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16260821 | pubmed:articleTitle | Reality orientation therapy combined with cholinesterase inhibitors in Alzheimer's disease: randomised controlled trial. | lld:pubmed |
| pubmed-article:16260821 | pubmed:affiliation | Department of Gerontology, Geriatrics and Psychiatry, Catholic University, Rome. graziano_onder@rm.unicatt.it | lld:pubmed |
| pubmed-article:16260821 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16260821 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16260821 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16260821 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16260821 | lld:pubmed |
